Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Jim Cramer, host of Mad Money, recently offered some important advice on how young people should approach investing and ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, ...

Abbott is well-positioned for another year of strong growth. The company projected organic sales growth between 7.5% and 8.5% ...

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The company's Q3 profit increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore ...

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on January 31st, the Senator disclosed that they had sold between $1,001 and $15,000 ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.